UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Involvement of insulin receptor substrates in cognitive impairment and Alzheimer's disease

Neural regeneration research, 2019-08, Vol.14 (8), p.1330-1334

2019

Volltextzugriff (PDF)

The prognostic value of the preoperative lung immune prognostic index in patients with urothelial bladder cancer undergoing radical cystectomy

International journal of clinical oncology, 2022-02, Vol.27 (2), p.396-402

2022

Volltextzugriff (PDF)

Prognostic role of the systemic immune–inflammation index in upper tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaboration

Cancer Immunology, Immunotherapy, 2021-09, Vol.70 (9), p.2641-2650

2021

Volltextzugriff (PDF)

Metformin treatment ameliorates diabetes‐associated decline in hippocampal neurogenesis and memory via phosphorylation of insulin receptor substrate 1

FEBS open bio, 2018-07, Vol.8 (7), p.1104-1118

2018

Volltextzugriff (PDF)

Re‐challenging chemotherapy after pembrolizumab in platinum‐refractory urothelial carcinoma

BJU international, 2023-04, Vol.131 (4), p.477-485

2023

Volltextzugriff (PDF)

Clinical benefit of continuing pembrolizumab treatment beyond progression in patients with metastatic urothelial carcinoma

Cancer Immunology, Immunotherapy, 2022-01, Vol.71 (1), p.229-236

2022

Volltextzugriff (PDF)

Blood platelet volume predicts treatment-specific outcomes of metastatic castration-resistant prostate cancer

International journal of clinical oncology, 2020-09, Vol.25 (9), p.1695-1703

2020

Volltextzugriff (PDF)

Reply to Cengiz Beyan and Esin Beyan. Mean platelet volume may not be a significant prognostic factor in patients with metastatic castration-resistant prostate cancer. Int J Clin Oncol 97(2), 3–4, 2020

International journal of clinical oncology, 2020-12, Vol.25 (12), p.2177-2178

2020

Volltextzugriff (PDF)

Modified Glasgow prognostic score is a pre-surgical prognostic marker of disease mortality in upper urinary tract urothelial carcinoma

Japanese journal of clinical oncology, 2021-01, Vol.51 (1), p.138-144

2021

Volltextzugriff (PDF)

Values of alkaline phosphatase at the diagnosis of castration resistance and response to primary androgen deprivation therapy as predictors of subsequent metastasis in non-metastatic castration-resistant prostate cancer

International journal of clinical oncology, 2020-03, Vol.25 (3), p.479-485

2020

Volltextzugriff (PDF)

Prognostic value of the fluctuation in the neutrophil–lymphocyte ratio at 6 weeks of pembrolizumab treatment is specific to the clinical response in metastatic urothelial carcinoma

Urologic oncology, 2022-07, Vol.40 (7), p.344.e11-344.e17

2022

Volltextzugriff (PDF)

Supine extraperitoneal laparoscopic nephroureterectomy without patient repositioning

International journal of urology, 2021-02, Vol.28 (2), p.163-168

2021

Volltextzugriff (PDF)

Abiraterone Acetate Versus Enzalutamide Against Chemo-Naïve Castration-Resistant Prostate Cancer With Full-Dose Induction

Curēus (Palo Alto, CA), 2024-07

2024

Volltextzugriff (PDF)

Bladder cancer invasion along a tension‐free vaginal mesh

IJU case reports, 2021-03, Vol.4 (2), p.104-107

2021

Volltextzugriff (PDF)

Laparoscopic partial nephrectomy for the horseshoe kidney with indocyanine green fluorescence guidance under the modified supine position

IJU case reports, 2022-07, Vol.5 (4), p.259-262

2022

Volltextzugriff (PDF)

Prognostic model with alkaline phosphatase, lactate dehydrogenase and presence of Gleason pattern 5 for worse overall survival in low-risk metastatic hormone-sensitive prostate cancer

Japanese journal of clinical oncology, 2021-11, Vol.51 (11), p.1665-1671

2021

Volltextzugriff (PDF)

Re: Concomitant Proton Pump Inhibitor Use and Survival in Urothelial Carcinoma Treated with Atezolizumab

European urology, 2021-04, Vol.79 (4), p.553-554

2021

Volltextzugriff (PDF)

Real‑world survival outcome comparing abiraterone acetate plus prednisone and enzalutamide for nonmetastatic castration‐resistant prostate cancer

Cancer medicine (Malden, MA), 2023-10, Vol.12 (19), p.19414-19422

2023

Volltextzugriff (PDF)

Efficacy of pembrolizumab and comprehensive CD274/PD-L1 profiles in patients previously treated with chemoradiation therapy as radical treatment in bladder cancer

Journal for immunotherapy of cancer, 2022-01, Vol.10 (1), p.e003868

2022

Volltextzugriff (PDF)

Impact of Dose-Effect in Smoking on the Effectiveness of Pembrolizumab in Patients with Metastatic Urothelial Carcinoma

Targeted oncology, 2021-03, Vol.16 (2), p.189-196

2021

Volltextzugriff (PDF)

Concurrent palliative radiation with pembrolizumab for platinum-refractory urothelial carcinoma is associated with improved overall survival

Clinical and translational radiation oncology, 2023-03, Vol.39, p.100558-100558, Article 100558

2023

Volltextzugriff (PDF)

Association Between Serum Magnesium Levels and Outcomes of Atezolizumab in Patients With Metastatic Urothelial Carcinoma

Anticancer research, 2024-05, Vol.44 (5), p.2117-2123

2024

Volltextzugriff (PDF)

Significance of prostate-specific antigen kinetics after three-dimensional conformal radiotherapy with androgen deprivation therapy in patients with localized prostate cancer

International journal of clinical oncology, 2018-04, Vol.23 (2), p.361-367

2018

Volltextzugriff (PDF)

1 – 25 von 89

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(87)
Mit Volltextzugriff
(79)

Publikationsform

Artikel
(87)
Berichte
(2)

Sprache

Englisch
(89)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Involvement of insulin receptor substrates in cognitive impairment and Alzheimer's disease

The prognostic value of the preoperative lung immune prognostic index in patients with urothelial bladder cancer undergoing radical cystectomy

Prognostic role of the systemic immune–inflammation index in upper tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaboration

Metformin treatment ameliorates diabetes‐associated decline in hippocampal neurogenesis and memory via phosphorylation of insulin receptor substrate 1

Re‐challenging chemotherapy after pembrolizumab in platinum‐refractory urothelial carcinoma

Clinical benefit of continuing pembrolizumab treatment beyond progression in patients with metastatic urothelial carcinoma

Blood platelet volume predicts treatment-specific outcomes of metastatic castration-resistant prostate cancer

Reply to Cengiz Beyan and Esin Beyan. Mean platelet volume may not be a significant prognostic factor in patients with metastatic castration-resistant prostate cancer. Int J Clin Oncol 97(2), 3–4, 2020

Modified Glasgow prognostic score is a pre-surgical prognostic marker of disease mortality in upper urinary tract urothelial carcinoma

Values of alkaline phosphatase at the diagnosis of castration resistance and response to primary androgen deprivation therapy as predictors of subsequent metastasis in non-metastatic castration-resistant prostate cancer

Prognostic value of the fluctuation in the neutrophil–lymphocyte ratio at 6 weeks of pembrolizumab treatment is specific to the clinical response in metastatic urothelial carcinoma

Supine extraperitoneal laparoscopic nephroureterectomy without patient repositioning

Abiraterone Acetate Versus Enzalutamide Against Chemo-Naïve Castration-Resistant Prostate Cancer With Full-Dose Induction

Risk stratification for the prediction of overall survival could assist treatment decision‐making at diagnosis of castration‐resistant prostate cancer: a multicentre collaborative study in Japan

Bladder cancer invasion along a tension‐free vaginal mesh

Laparoscopic partial nephrectomy for the horseshoe kidney with indocyanine green fluorescence guidance under the modified supine position

Prognostic model with alkaline phosphatase, lactate dehydrogenase and presence of Gleason pattern 5 for worse overall survival in low-risk metastatic hormone-sensitive prostate cancer

Re: Concomitant Proton Pump Inhibitor Use and Survival in Urothelial Carcinoma Treated with Atezolizumab

Real‑world survival outcome comparing abiraterone acetate plus prednisone and enzalutamide for nonmetastatic castration‐resistant prostate cancer

Efficacy of pembrolizumab and comprehensive CD274/PD-L1 profiles in patients previously treated with chemoradiation therapy as radical treatment in bladder cancer

Impact of Dose-Effect in Smoking on the Effectiveness of Pembrolizumab in Patients with Metastatic Urothelial Carcinoma

Early Prostate-Specific Antigen (PSA) Change at Four Weeks of the First-Line Treatment Using Abiraterone and Enzalutamide Could Predict Early/Primary Resistance in Metastatic Castration-Resistant Prostate Cancer

Concurrent palliative radiation with pembrolizumab for platinum-refractory urothelial carcinoma is associated with improved overall survival

Association Between Serum Magnesium Levels and Outcomes of Atezolizumab in Patients With Metastatic Urothelial Carcinoma

Significance of prostate-specific antigen kinetics after three-dimensional conformal radiotherapy with androgen deprivation therapy in patients with localized prostate cancer

Suchergebnisse filtern